Saeed Aghebat Bekheir | Translational Research | Research Excellence Award

Dr. Saeed Aghebat Bekheir | Mental Health | Research Excellence Award

PhD Candidate in Toxicology | Tehran University of Medical Sciences | Iran

Dr. Saeed Aghebat Bekheir is a dedicated researcher and PhD candidate in Toxicology at Tehran University of Medical Sciences, working under the mentorship of Prof. Abdollahi. His research focuses on mitochondrial toxicology, cardiotoxicity, and mechanistic modeling of toxin-induced bioenergetic failure, with a particular emphasis on developing therapeutic strategies for aluminum phosphide–induced mitochondrial dysfunction. Dr. Aghebat Bekheir has demonstrated expertise in a wide range of experimental approaches, including in vivo animal studies, cellular and molecular assays, and in vitro toxicological models, integrating mechanistic toxicology with translational research to address acute mitochondrial injury and cardiotoxicity. His scholarly contributions are reflected in several peer-reviewed publications in high-impact journals, and he actively serves as a reviewer for multiple journals in toxicology and biomedical sciences, highlighting his commitment to advancing scientific rigor and dissemination. Collaboratively, he engages in research partnerships within the toxicology and mitochondrial research community, fostering interdisciplinary approaches to environmental and translational toxicology challenges. His work contributes to a deeper understanding of oxidative stress, bioenergetic disturbances, and cardiotoxic mechanisms, with broader implications for public health and therapeutic innovation. Beyond his laboratory and scholarly pursuits, Dr. Aghebat Bekheir’s research emphasizes societal relevance by addressing environmental toxicants and their impacts on human health, providing foundational knowledge for developing interventions to mitigate toxicity-related diseases. Through his professional memberships, editorial activities, and collaborative initiatives, he actively contributes to shaping the global toxicology landscape, promoting evidence-based strategies, and inspiring emerging researchers in the field. His ongoing research underscores a commitment to integrating scientific excellence with practical solutions for human health, reflecting both scholarly distinction and societal impact. He has 23 citations from 5 documents with an h-index of 3.

Profiles: Google Scholar | Scopus

Featured Publications

1. Ghanati, K., Jahanbakhsh, M., Shakoori, A., Aghebat-Bekheir, S., … (2024). The association between polycystic ovary syndrome and environmental pollutants based on animal and human study; a systematic review.

2. Ghanati, K., Eghbaljoo, H., Akbari, N., Mazaheri, Y., Aghebat-Bekheir, S., … (2023). Determination of melamine contamination in milk with various packaging: A risk assessment study.

3. Aghebat-Bekheir, S., Abdollahi, M. (2024). Discovering the most impactful treatments for aluminum phosphide cardiotoxicity gleaned from systematic review of animal studies.

4. Reihani, A., Marboutian, F., Aghebat-Bekheir, S., Reyhani, A., Akhgari, M. (2024). Diagnostic aspects of paraquat in the forensic toxicology: A systematic review.

5. Aghebat-Bekheir, S., Hekmatirad, S., Asar, N., Abdollahi, M. (n.d.). Aluminum phosphide as a model for exploring acute mitochondrial disorders.

Maryam Tehranipour | Pharmacology | Best Researcher Award

Assoc. Prof. Dr. Maryam Tehranipour | Pharmacology | Best Researcher Award

Animal Physiology | Islamic Azad University | Iran

Dr. Maryam Tehranipour is an accomplished Associate Professor in the Department of Biology at the Islamic Azad University, Mashhad, Iran, recognized for her distinguished contributions to the fields of diabetes, metabolic disorders, neurobiology, oxidative stress, and cancer biology. Holding a Ph.D. in Animal Physiology, she has built a dynamic academic and research career integrating cellular physiology, pharmacology, and molecular mechanisms of disease. Her extensive publication record spans a broad spectrum of biomedical investigations, including neuroprotective strategies, natural product pharmacology, nanomedicine, and experimental models of diabetes and neurodegeneration. Dr. Tehranipour’s pioneering studies have elucidated the roles of oxidative damage, angiogenesis, and neuronal regeneration in disease progression and therapeutic recovery, particularly highlighting the potential of bioactive compounds and nanocarrier systems in drug design and targeted therapy. Her collaborative work has advanced understanding of diabetic complications, nerve injury repair, and cancer cell modulation through natural and synthetic agents. Beyond her prolific research output, she has played a significant role in mentoring undergraduate, graduate, and doctoral students, fostering scientific rigor and innovation in physiological research. Her scholarly influence is reflected through her indexed publications, contributions to interdisciplinary research networks, and global collaborations that link physiology, biochemistry, and nanotechnology for translational health impact. Dr. Tehranipour’s scientific endeavors emphasize the integration of experimental biology with clinical relevance, aiming to bridge laboratory discoveries with therapeutic applications. Through her ongoing research, she continues to contribute meaningfully to global biomedical science, particularly in developing sustainable and biologically safe therapeutic interventions addressing chronic and degenerative diseases that pose major public health challenges. She has 238 citations from 53 documents with an h-index of 9.

Profile: Scopus 

Featured Publications

1. The Umbelliprenin-CTAB cellulose nanocrystal delivery system prevents hyperglycemia in diabetic rats by activating the insulin receptor IR/PDK1 pathway. (2025). Scientific Reports. Open access.

2. The effects of N-butanol and ethyl acetate fractions of Ferula asafoetida hydroalcoholic extract on the expression of VEGF and FGF genes in the chorioallantoic membrane of chick embryos. (2025). Journal of Veterinary Research.Open access.

3. Bimetallic-based colorimetric aptasensor for the quantitative analysis of ampicillin using catalytic activity of ZrFe metal–organic framework and terminal deoxynucleotidyl transferase-assisted signal amplification. (2025). Bionanoscience. Open access.

4. The effect of Ziziphora clinopodioides hydroalcoholic extract on the neuronal density and histopathology of the hippocampal area CA2 in streptozotocin-induced Alzheimer’s model in male rats. (2025). Journal of Chemical Health Risks. Open access.

5. A novel alpha-terpineol-loaded niosome formulation coated with hyaluronic acid and evaluation of its anticancer properties in vitro. (2025). Journal of Molecular Liquids. Open access.